Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)

for
Bronchiolitis Obliterans Syndrome, Bronchiolitis Obliterans,
Location: Seattle WA, Stanford CA, Ann Arbor MI, Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT05922761

Phase 2, Recruiting
Active & Responsive

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

for
Colorectal Cancer
Location: Seattle WA, Salt Lake City UT, Fountain Valley CA,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05234177

Recruiting
Active & Responsive

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for
Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis,
Location: Seattle WA, San Francisco CA, Los Angeles CA,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT05786924

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

for
Alzheimer Disease
Location: Bellevue WA, Los Angeles CA, Chino CA, Anaheim CA,
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sex: All

Age: 55 - 70+

Code: NCT06585787

Phase 3, Recruiting
Active & Responsive

Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy

for
Diabetic Peripheral Neuropathic Pain
Location: Bellevue WA, Medford OR, Meridian ID, Sacramento CA,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT06628908

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

for
Depressive Disorder, Major
Location: Bellevue WA, Surrey, Portland OR, Richmond, Kelowna,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07412756

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

for
Diabetic Macular Edema (DME)
Location: Bellevue WA, Sacramento CA, Bakersfield CA, Modesto CA,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT07734844

Phase 3, Recruiting
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Seattle WA, Portland OR, Billings MT, San Francisco CA,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting
Active & Responsive

A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

for
Breast Cancer Screening, Artificial Intelligence (AI)
Location: Seattle WA, Los Angeles CA, San Diego CA, Madison WI,
Sponsor: Jonsson Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT06934239

Phase 4, Recruiting
Active & Responsive

Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates

for
Liver Transplant
Location: Seattle WA, Portland OR, San Francisco CA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT06075745

Phase 2, Recruiting
Active & Responsive

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

for
Glioma, Astrocytoma, Grade IV, IDH1-mutant Glioma,
Location: Seattle WA, Portland OR, Billings MT, San Francisco CA,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT05303519

Phase 3, Recruiting
Active & Responsive

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

for
Huntington Disease
Location: Seattle WA, Portland OR, Sacramento CA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 21 - 70

Code: NCT07326709

Phase 3, Recruiting
Active & Responsive

InMotion - Telehealth Delivered Exercise Promotion to Treat Major Depression After TBI

for
TBI (Traumatic Brain Injury), Depressive Disorder, Major,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18 - 64

Code: NCT06005194

Recruiting
Active & Responsive

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

for
Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation
Location: Seattle WA, Portland OR, Spokane WA, Boise ID, Calgary,
Sponsor: Chris Goss

Sex: All

Age: 6+

Code: NCT05548283

Recruiting
Active & Responsive

IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study)

for
Nontuberculous Mycobacterium Infection
Location: Seattle WA, Denver CO, Minneapolis MN, Dallas TX,
Sponsor: Chris Goss

Sex: All

Age: 18+

Code: NCT04294043

Phase 1, Recruiting
Active & Responsive

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

for
Cystic Fibrosis
Location: Seattle WA, San Francisco CA, Los Angeles CA,
Sponsor: SpliSense Ltd.

Sex: All

Age: 18+

Code: NCT06429176

Phase 2, Recruiting
Active & Responsive

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

for
Castration-Resistant Prostate Cancer (CRPC),
Location: Seattle WA, West Valley City UT, Los Angeles CA,
Sponsor: Monte Rosa Therapeutics, Inc

Sex: Male

Age: 18+

Code: NCT07745361

Phase 2, Recruiting
Active & Responsive

NEPTUNE Match Study

for
Nephrotic Syndrome in Children,
Location: Seattle WA, Spokane WA, Kansas City KS, Kansas City MO,
Sponsor: University of Michigan

Sex: All

Age: 1 - 70+

Code: NCT04571658

Recruiting
Active & Responsive

Serial Blood Count Study

for
Cyclic Neutropenia, Congenital Neutropenia, Neutropenia
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 5+

Code: NCT07066085

Early Phase 1, Recruiting
Active & Responsive

A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

for
Crohn's Disease
Location: Seattle WA, New Westminster, Calgary, Las Vegas NV,
Sponsor: Takeda

Sex: All

Age: 18 - 70+

Code: NCT06233461

Phase 2, Recruiting